Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Predictive Strength of the LACE+ Index With the MedWise Rise Score on Hospital Readmission Rates: a Non-inferiority Observational Study

NCT04365673 is registered in ClinicalTrials.gov with Tabula Rasa HealthCare as lead sponsor.

NCT NCT04365673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04365673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Predictive Strength of the LACE+ Index With the MedWise Rise Score on Hospital Readmission Rates: a Non-inferiority Observational Study
Lead sponsor
Tabula Rasa HealthCare
Phase
Observational
Overall status
Terminated
Start date
July 7, 2020
Completion date
March 1, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hospitalism